Northern Manhattan Study of Metabolism and Mind
NOMEM
3 other identifiers
observational
1,000
1 country
1
Brief Summary
Pre-diabetes, type 2 diabetes, and their related conditions, adiposity and insulin resistance, are more prevalent in minorities Northern Manhattan compared to the general population of the United States. Despite knowledge of the main biologic determinants of these conditions (high caloric intake and sedentarism) the prevalence of these conditions continue to increase. In addition, these conditions can cause mental health problems including increased depressive symptoms and cognitive impairment. Thus, the investigators decided to conduct a community based study of middle aged Hispanic men and women aged 50 to 64 years at baseline in order to:
- 1.Document the prevalence and incidence, of pre-diabetes, diabetes, overweight, obesity, and associated conditions (e.g. dyslipidemia, hypertension).
- 2.Study how social determinants of health (SDOH) affect these conditions.
- 3.Study the consequences of these conditions on aging and mental health outcomes, including cognitive impairment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 8, 2015
CompletedFirst Posted
Study publicly available on registry
June 12, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
May 7, 2025
May 1, 2025
14.5 years
June 8, 2015
May 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cognition
cognitive change over at least 3 follow-ups measured with the Selective Reminding Test, Color trails test, and Animal fluency tests.
6 years
Secondary Outcomes (3)
Transitions in diabetes status
6 years
Metabolic syndrome
6 years
Depressive symptoms
6 years
Study Arms (3)
Diabetes
Defined by clinical history or HbA1c criteria (HbA1c greater of equal to 6.5%)
Pre-diabetes
Defined by HbA1c criteria (5.7 to 6.4%)
Normal glucose tolerance
Defined by HbA1c criteria (\< 5.7%)
Eligibility Criteria
Middle aged Hispanics from Northern Manhattan, New York City
You may qualify if:
- Self identified Hispanic (any Hispanic subgroup)
- Man or woman.
- Between the ages of 50 and 64 years at baseline
You may not qualify if:
- History of cancer other than non-melanoma skin cancer
- The expectation of moving out for the country permanently before during the study period
- Presence of a clinical diagnosis of dementia, which we anticipate will be unlikely in this age group.
- Visual, hearing, or physical impairment that precludes active participation in the study and inability to complete study questionnaires.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University Irving Medical Center
New York, New York, 10032, United States
Biospecimen
whole blood for DNA extraction, plasma, sera
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose A. Luchsinger, MD
Columbia University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine and Epidemiology
Study Record Dates
First Submitted
June 8, 2015
First Posted
June 12, 2015
Study Start
January 1, 2012
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
May 7, 2025
Record last verified: 2025-05